Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Org 37462 (Ganirelix) dose-finding in Japanese females for IVF-ICSI
NCT00988260Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2003
- Primary completion
- Apr 2004
- Modality
- Peptides, Small Molecules
01
Overview
Phase 2, randomised trial of ganirelix in female infertility (3 arms), sponsored by Organon & Co. Primary endpoints: Incidence of Luteinizing Hormone (LH) rise and Intrauterine vital pregnancy rate. Started Feb 2003; status: completed.
02
Drugs
ganirelix
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT00988260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00988260.